Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population

Cancer Epidemiology

Volumn 35, Issue 4, 2011, Pages

  Liu, Weijia ^a   Zhu, Enxin ^a   Wang, Ru ^a   Wang, Lihong ^b   Gao, Lu ^a   Yang, Xuesong ^a   Liu, Tingjiao ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Graduate School of Northeastern University   (China)

Author keywords

Cyclin D1; Polymorphism; Salivary gland tumors

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHEEK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND TUMOR; PLEOMORPHIC ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALIVARY GLAND; SALIVARY GLAND TUMOR; SUBMANDIBULAR GLAND;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENES, BCL-1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SALIVARY GLAND NEOPLASMS;

EID: 79960608504     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.11.001     Document Type: Article

References (44)

1. Barnes LEJ, Reichart P, Sidransky D, editors. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Edited by Lyon, IARC Press, 2005.
2. Yang L., Hashimura K., Qin C., Shrestha P., Sumitomo S., Mori M. Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential. Virchows Arch A Pathol Anat Histopathol 1993, 422:481-486.
3. Cardoso W.P., Denardin O.V., Rapoport A., Araujo V.C., Carvalho M.B. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands. Sao Paulo Med J 2000, 118:69-74.
4. Daa T., Kaku N., Kashima K., Nakayama I., Yokoyama S. Expression of beta-catenin, E-cadherin and Cyclin D1 in adenoid cystic carcinoma of the salivary gland. J Exp Clin Cancer Res 2005, 24:83-87.
5. Liu T., Zhu E., Wang L., Okada T., Yamaguchi A., Okada N. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma. Hum Pathol 2005, 36:962-970.
6. Sherr C.J. D-type cyclins. Trends Biochem Sci 1995, 20:187-190.
7. Masamha C.P., Benbrook D.M. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res 2009, 69:6565-6572.
8. Mochizuki M., Kwon Y.W., Yodoi J., Masutani H. Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1 pathway. Antioxid Redox Signal 2009, 11:2957-2971.
9. Callender T., el-Naggar A.K., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994, 74:152-158.
10. Pignataro L., Capaccio P., Carboni N., Pruneri G., Ottaviani A., Buffa R., et al. p53 and cyclinX D1 protein expression in carcinomas of the parotid gland. Anticancer Res 1998, 18:1287-1290.
11. Sarbia M., Stahl M., Fink U., Heep H., Dutkowski P., Willers R., et al. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer 1999, 84:86-91.
12. Bahnassy A.A., Zekri A.R., El-Houssini S., El-Shehaby A.M., Mahmoud M.R., Abdallah S., et al. Cyclin A and Cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol 2004, 4:22.
13. Papadimitrakopoulou V., Izzo J.G., Liu D.D., Myers J., Ceron T.L., Lewin J., et al. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila Pa) 2009, 2:14-21.
14. Roy P.G., Pratt N., Purdie C.A., Baker L., Ashfield A., Quinlan P., et al. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer 2010, 127:355-360.
15. Zhou C.X., Gao Y. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. Oncol Rep 2006, 16:505-511.
16. Sequeiros-Santiago G., Garcia-Carracedo D., Fresno M.F., Suarez C., Rodrigo J.P., Gonzalez M.V. Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep 2009, 21:1215-1222.
17. Betticher D.C., Thatcher N., Altermatt H.J., Hoban P., Ryder W.D., Heighway J. Alternate splicing produces a novel Cyclin D1 transcript. Oncogene 1995, 11:1005-1011.
18. Guo Y., Yang K., Harwalkar J., Nye J.M., Mason D.R., Garrett M.D., et al. Phosphorylation of Cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 2005, 24:2599-2612.
19. Benzeno S., Lu F., Guo M., Barbash O., Zhang F., Herman J.G., et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of Cyclin D1. Oncogene 2006, 25:6291-6303.
20. McKay J.A., Douglas J.J., Ross V.G., Curran S., Murray G.I., Cassidy J., et al. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int J Cancer 2000, 88:77-81.
21. Zheng Y., Shen H., Sturgis E.M., Wang L.E., Eicher S.A., Strom S.S., et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 2001, 22:1195-1199.
22. Wang L., Habuchi T., Takahashi T., Mitsumori K., Kamoto T., Kakehi Y., et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 2002, 23:257-264.
23. Izzo J.G., Papadimitrakopoulou V.A., Liu D.D., den Hollander P.L., Babenko I.M., Keck J., et al. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 2003, 95:198-205.
24. Le Marchand L., Seifried A., Lum-Jones A., Donlon T., Wilkens L.R. Association of the Cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 2003, 290:2843-2848.
25. Qiuling S., Yuxin Z., Suhua Z., Cheng X., Shuguang L., Fengsheng H. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 2003, 24:1499-1503.
26. Monteiro E., Varzim G., Pires A.M., Teixeira M., Lopes C. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure. Cancer Detect Prev 2004, 28:237-243.
27. Nishimoto I.N., Pinheiro N.A., Rogatto S.R., Carvalho A.L., Simpson A.J., Caballero O.L., et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 2004, 40:604-610.
28. Yu J., Habuchi T., Tsuchiya N., Nakamura E., Kakinuma H., Horikawa Y., et al. Association of the Cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma. J Urol 2004, 172:2410-2413.
29. Rydzanicz M., Golusinski P., Mielcarek-Kuchta D., Golusinski W., Szyfter K. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 2006, 263:43-48.
30. Forones N.M., de Lima J.M., de Souza L.G., da Silva I.D. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J Gastrointest Cancer 2008, 39:118-123.
31. Satinder K., Chander S.R., Pushpinder K., Indu G., Veena J. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Mol Cell Biochem 2008, 315:151-157.
32. Lu C., Dong J., Ma H. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 2009, 116:571-575.
33. Holley S.L., Parkes G., Matthias C., Bockmuhl U., Jahnke V., Leder K., et al. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 2001, 159:1917-1924.
34. Sathyan K.M., Nalinakumari K.R., Abraham T., Kannan S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 2008, 44:689-697.
35. Holley S.L., Matthias C., Jahnke V., Fryer A.A., Strange R.C., Hoban P.R. Association of Cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol 2005, 41:156-160.
36. Sathyan K.M., Nalinakumari K.R., Abraham T., Kannan S. Influence of single nucleotide polymorphisms in H-Ras and Cyclin D1 genes on oral cancer susceptibility. Oral Oncol 2006, 42:607-613.
37. Jia A., Gong J., Li Y., Hao Z., Chang X., Dai F., et al. GG genotype of Cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China. Scand J Gastroenterol 2008, 43:1353-1359.
38. Tan X.L., Nieters A., Kropp S., Hoffmeister M., Brenner H., Chang-Claude J. The association of Cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 2008, 122:2573-2580.
39. Tahara T., Arisawa T., Shibata T., Yamashita H., Hirata I. Association between Cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population. Hepatogastroenterology 2009, 56:1232-1235.
40. Akkiz H., Bayram S., Bekar A., Akgöllü E., Ozdil B. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 2010, 34:298-302.
41. Yaylim-Eraltan I., Arikan S., Yildiz Y., Cacina C., Ergen H.A., Tuna G., et al. The influence of Cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 2010, 30:2875-2880.
42. Yuan L., Gu X., Shao J., Wang M., Wang M., Zhu Q., et al. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 2010, 29:611-617.
43. Ni J., Wang M., Wang M., Fu S., Zhou D., Zhang Z., et al. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. J Cancer Res Clin Oncol 2010, [Epub ahead of print].
44. Patel R.S., Rose B., Bawdon H., Hong A., Lee C.S., Fredericks S., et al. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland. Histopathology 2007, 51:691-696.